Cognitive enhancers are drugs and supplements, which are majorly used by patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging. In addition, these drugs are used by health individuals to improve cognitive functions such as memory, intelligence, motivation, stamina, alertness attention, and concentration
For More Info, Get Sample : www.researchbeam.com/cognitive-and…et/request-sample
The global cognitive and memory enhancer drugs market was valued at $3,680 million in 2016, and is projected to reach $6,598 million by 2023, growing at a CAGR of 8.6% from 2017 to 2023. The growth of the global cognitive and memory enhancer drugs market is driven by surge in geriatric population and rise in prevalence of neurological & memory-related disorders.
Furthermore, the benefits offered by cognitive drugs such as improved memory and reasoning fuel the market growth. However, ethical issues related to the use of these drugs impede the market growth.
The global cognitive and memory enhancer drugs market is segmented on the basis of product, application, and region. Based on product, the market is categorized into Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall, and others.
The applications covered in the study include disease treatment, academic performance, athletic performance, and others. Disease treatment segment is further bifurcated into developmental conditions and neurodegenerative disease.
By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging trends and dynamics in the global cognitive and memory enhancer drugs market.
- This study provides the competitive landscape of the global market to predict the competitive environment across geographies.
- This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
- Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
- Region- and country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
Enquire About Report : www.researchbeam.com/cognitive-and…uire-about-report
- Disease Treatment
- Developmental Conditions
- Neurodegenerative Conditions
- Academic Performance
- Athletic Performance
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
Also Request For Report: www.researchbeam.com/cognitive-and…/purchase-enquiry
The key players profiled in this report are as follows:
- Pfizer Inc.
- Eisai Co., Ltd.
- Allergan, Inc.
- Novartis AG
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- AlternaScript LLC
- Cephalon, Inc. (Teva Pharmaceutical Industries Ltd.)
Table Of Content
- CHAPTER 1: INTRODUCTION
- CHAPTER 2: EXECUTIVE SUMMARY
- CHAPTER 3: MARKET OVERVIEW
- CHAPTER 4: COGNITIVE AND MEMORY ENHANCER DRUGS MARKET, BY PRODUCT
- CHAPTER 5: COGNITIVE AND MEMORY ENHANCER DRUGS MARKET BY APPLICATION
- CHAPTER 6: COGNITIVE AND MEMORY ENHANCER DRUGS MARKET BY REGION
- CHAPTER 7: COMPANY PROFILES
Category: Market Research Publishers and RetailersCompany about: We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports fro ...